BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36800601)

  • 1. Reverse predictive analysis of Rhizoma Pinelliae and Rhizoma Coptidis on differential miRNA target genes in lung adenocarcinoma.
    Meng T; Liu J; Chang H; Qie R
    Medicine (Baltimore); 2023 Feb; 102(7):e32999. PubMed ID: 36800601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.
    Zeng T; Ling C; Liang Y
    Technol Health Care; 2024; 32(S1):523-542. PubMed ID: 38759074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Network pharmacology research and experimental validation of "Coptidis Rhizoma-Pinelliae Rhizoma" in treating gastric carcinoma].
    Wang EY; Wang JH; Ding R; Li ZQ; Zhai MT; Ge RR; Zhou P; Wang L; Huang JL
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1779-1788. PubMed ID: 32489061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Mechanism of Rhizoma Coptidis-Eupatorium fortunei Medicine in the Treatment of Type 2 Diabetes Based on Network Pharmacology and Molecular Docking.
    Li H; Luo D; Wei R; Sun M; Zhang X; Deng H; Bian W; Wei H; Huang Y
    Biomed Res Int; 2022; 2022():7978258. PubMed ID: 36452059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on relevance mining of "core drug action target" in Dictionary of Traditional Chinese Medicine Prescriptions].
    Wang B; Zhou RR; Tang SH
    Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(19):3919-3926. PubMed ID: 30453719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Rhizoma Coptidis in epilepsy with network pharmacology.
    Huang D; Lv Y; Lu C; Zhang B; Fu Z; Huang Y
    Allergol Immunopathol (Madr); 2022; 50(3):138-150. PubMed ID: 35527668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Rhizoma Coptidis against type 2 diabetes mellitus explored by network pharmacology combined with molecular docking and experimental validation.
    An W; Huang Y; Chen S; Teng T; Shi Y; Sun Z; Xu Y
    Sci Rep; 2021 Oct; 11(1):20849. PubMed ID: 34675276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untargeted Metabolomics Based on Ultra-High-Performance Liquid Chromatography Coupled with Quadrupole Orbitrap High-Resolution Mass Spectrometry for Differential Metabolite Analysis of Pinelliae Rhizoma and Its Adulterants.
    Wang J; Cui J; Liu Z; Yang Y; Li Z; Liu H
    Molecules; 2024 May; 29(9):. PubMed ID: 38731650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology.
    Yang Y; Qian C; Wu R; Wang R; Ou J; Liu S
    BMC Complement Med Ther; 2023 Jan; 23(1):11. PubMed ID: 36647064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the therapeutic mechanisms of Coptidis Rhizoma in gastric precancerous lesions: a network pharmacology approach.
    Ye X; Yang C; Xu H; He Q; Sheng L; Lin J; Wang X
    Discov Oncol; 2024 Jun; 15(1):211. PubMed ID: 38837097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on aconite prescriptions with incompatible herbs in different areas based on association rules and analysis on compatibility features].
    Zuo T; Fan XS; Tian S; Jiang CX; Chen F
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1198-202. PubMed ID: 26226770
    [TBL] [